$0.9500
0.033.26%
Pre-Market: 8:03 AM EDT
Comments
Loading...
Indaptus Therapeutics (NASDAQ:INDP) Stock, Earnings Estimates, EPS, And Revenue
Indaptus Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 12
EPS Estimate
$-0.410
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Indaptus Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Indaptus Therapeutics (INDP) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-12 | $-0.32 | $-0.42 | 23.8 % |
| Q2 | 2024-08-12 | $-0.47 | $-0.54 | 13.0 % |
| Q1 | 2024-05-08 | $-0.45 | $-0.44 | -2.27 % |
| Q4 | 2024-03-13 | $-0.46 | $-0.54 | 14.8 % |
Indaptus Therapeutics (INDP) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Indaptus Therapeutics (NASDAQ:INDP) reporting earnings?
Indaptus Therapeutics (INDP) is scheduled to report earnings on March 12, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
What were the latest earnings per share (EPS) for Indaptus Therapeutics (NASDAQ:INDP)?
The Actual EPS was $-0.32, which beat the estimate of $-0.42.
What were Indaptus Therapeutics’s (NASDAQ:INDP) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.